CRISPR Therapeutics AG CRSP
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 64.81 | 1,916 | -5.87 | -106 | -4.98 | 2,245 |
| 2025Q2 | 48.64 | 1,711 | -11.78 | -209 | -9.94 | 2,030 |
| 2025Q1 | 34.03 | 1,829 | -7.23 | -136 | -6.17 | 2,166 |
| 2024Q4 | 39.36 | 1,932 | -1.93 | -37 | -1.66 | 2,242 |
| 2024Q3 | 46.98 | 1,940 | -4.38 | -86 | -3.74 | 2,256 |
| 2024Q2 | 54.01 | 1,981 | -6.22 | -126 | -5.29 | 2,340 |
| 2024Q1 | 68.16 | 2,084 | -5.88 | -117 | -4.99 | 2,439 |
| 2023Q4 | 62.60 | 1,883 | 4.95 | 89 | 4.14 | 2,230 |
| 2023Q3 | 45.39 | 1,728 | -6.33 | -112 | -5.24 | 2,087 |
| 2023Q2 | 56.14 | 1,816 | -4.24 | -78 | -3.50 | 2,197 |
| 2023Q1 | 45.23 | 1,855 | -2.85 | -53 | -2.37 | 2,244 |
| 2022Q4 | 40.65 | 1,875 | -5.78 | -111 | -4.81 | 2,243 |
| 2022Q3 | 65.35 | 1,954 | -8.63 | -175 | -7.25 | 2,353 |
| 2022Q2 | 60.77 | 2,091 | -8.57 | -186 | -7.33 | 2,463 |
| 2022Q1 | 62.77 | 2,245 | -7.72 | -179 | -6.69 | 2,606 |
| 2021Q4 | 75.78 | 2,399 | -5.75 | -141 | -5.07 | 2,752 |
| 2021Q3 | 111.93 | 2,513 | -4.97 | -127 | -4.44 | 2,822 |
| 2021Q2 | 161.89 | 2,604 | 34.44 | 759 | 31.26 | 2,900 |
| 2021Q1 | 121.85 | 1,805 | -6.52 | -113 | -5.98 | 1,958 |
| 2020Q4 | 153.11 | 1,664 | -7.12 | -107 | -6.46 | 1,828 |